Roche Diagnostics launches first in vitro diagnostic ROS1 immunohistochemistry assay

Roche Diagnostics today announced the launch of the VENTANA ROS1 (SP384) Antibody, the first and only in vitro diagnostic ROS1 immunohistochemistry (IHC) assay. The test detects the presence of ROS1 protein in tissue, and may be useful in identifying ROS1-positive lung cancer cases.

Mutations of the ROS1 gene are present in some NSCLC cases and can help indicate which patients would respond with a targeted treatment.

As these types of cancer are rare, found in up to two percent of non-small cell lung cancer cases, the use of a ROS1 IHC biomarker may provide a cost-effective and efficient means of identifying cases with elevated ROS1 protein expression, before confirming by another method, such as by fluorescence in situ hybridization (FISH) or next­ generation sequencing (NGS).

Our highly sensitive ROS1 test is the first in vitro diagnostic test available for recommended lung cancer testing guidelines, with the added benefit of rapid turnaround time. While this is important in non-small cell lung cancer cases today, ROS1 is also being investigated in a number of clinical trials in other cancer types.”

Pierre Hazlewood, Marketing Director at Roche Diagnostics

The VENTANA ROS1 (SP384) Antibody is a CE in vitro diagnostic device and is available for use on Roche's BenchMark series of automated staining instruments.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Roche Sequencing and Life Science. (2019, June 20). Roche Diagnostics launches first in vitro diagnostic ROS1 immunohistochemistry assay. News-Medical. Retrieved on July 23, 2024 from https://www.news-medical.net/news/20190610/Roche-Diagnostics-launches-first-in-vitro-diagnostic-ROS1-immunohistochemistry-assay.aspx.

  • MLA

    Roche Sequencing and Life Science. "Roche Diagnostics launches first in vitro diagnostic ROS1 immunohistochemistry assay". News-Medical. 23 July 2024. <https://www.news-medical.net/news/20190610/Roche-Diagnostics-launches-first-in-vitro-diagnostic-ROS1-immunohistochemistry-assay.aspx>.

  • Chicago

    Roche Sequencing and Life Science. "Roche Diagnostics launches first in vitro diagnostic ROS1 immunohistochemistry assay". News-Medical. https://www.news-medical.net/news/20190610/Roche-Diagnostics-launches-first-in-vitro-diagnostic-ROS1-immunohistochemistry-assay.aspx. (accessed July 23, 2024).

  • Harvard

    Roche Sequencing and Life Science. 2019. Roche Diagnostics launches first in vitro diagnostic ROS1 immunohistochemistry assay. News-Medical, viewed 23 July 2024, https://www.news-medical.net/news/20190610/Roche-Diagnostics-launches-first-in-vitro-diagnostic-ROS1-immunohistochemistry-assay.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Troponin T test provides possible one hour diagnosis of heart attack